TITLE:
Immunotherapy for the Post-Infectious Sequela of SARS-CoV-2 Infection
AUTHORS:
David S. Younger
KEYWORDS:
SARS-CoV-2, Covid-19, Intravenous Immune Globulin, IVIg, Pediatric Multi-System Inflammatory Syndrome
JOURNAL NAME:
World Journal of Neuroscience,
Vol.10 No.2,
May
18,
2020
ABSTRACT: The SARS-CoV-2 2019 pandemic is creating challenges
to the management of post-infectious autoimmunity in childhood and adult
Covid-19 cases due to its high case fatality. Nearly all of the agents
envisioned to treat Covid-19 illness, including the newly recognized pediatric
multi-system inflammatory syndrome, impact post-infectious mechanisms in
keeping with the multiplier effect of infection, immunity and inflammation,
known as I-Cubed (I3).